STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek GlobeNewswire October 20, 2025 HORSHAM, Penn., Oct. 20, 2025 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today provided an […]

Maxus Mining Announces Appointment of Robert Eckford as Technical Advisor & Marketing Agreement GlobeNewswire October 20, 2025 VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) — Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce the appointment of Mr. Robert Eckford as a Technical Advisor to the Company.

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference GlobeNewswire October 20, 2025 NORCROSS, Ga., Oct. 20, 2025 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will participate in the H.C. Wainwright 9th Annual MASH Virtual

CU Denver's Executive MBA in Aviation Taps Global Leaders to Train Next-Gen Executives Faculty includes top voices from United Airlines, WestJet, Hawaiian Airlines, and the FAA, bringing real-world leadership into the classroom. GlobeNewswire October 20, 2025 Denver, CO, Oct. 20, 2025 (GLOBE NEWSWIRE) — The University of Colorado Denver (CU Denver) Business School, today announced

CervoMed to Present at the Emerging Growth Conference GlobeNewswire October 20, 2025 BOSTON, Oct. 20, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that Matthew Winton, Ph.D., Chief Commercial and Business Officer, will present at the Emerging

CareCloud to Present at the 2025 ThinkEquity Conference GlobeNewswire October 20, 2025 Company to highlight AI innovation, strategic acquisitions, and continued growth momentum SOMERSET, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology solutions, announced today its participation in the ThinkEquity Conference, taking

GSI Technology to Announce Fiscal Second Quarter 2026 Results on October 30, 2025 GlobeNewswire October 20, 2025 SUNNYVALE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), developer of the Gemini (R) Associative Processing Unit (APU) for AI and high-performance parallel computing (HPPC) and a leading provider of high-performance memory solutions for

Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting(R) 2025 and ASN Kidney Week 2025 GlobeNewswire October 20, 2025 SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, today announced that new preclinical data from its ACT-UP1 platform will be presented at

MBX Biosciences to Participate in November Investor Conferences GlobeNewswire October 20, 2025 CARMEL, Ind., Oct. 20, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and

zSpace Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Market and Regains Compliance with Nasdaq Listing Requirements Strategic move positions Company for sustained listing compliance and better alignment with business profile GlobeNewswire October 20, 2025 SAN JOSE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented